James River Group Holdings, Inc. reported a significant turnaround in Q4 2025, driven by improved underwriting profitability and operational efficiencies, particularly in the Excess and Surplus Lines segment. The company's strategic focus on smaller, profitable accounts and cost reductions has strengthened its financial position and improved profitability.
Net income available to common shareholders was $30.1 million, a substantial improvement from a loss of $94.0 million in the prior year quarter.
positiveCombined ratio improved significantly to 94.1% from 155.1% in the prior year quarter, with underwriting profit of $8.6 million compared to a loss of $58.1 million.
positiveExpense ratio decreased to 29.2% from 43.7% year-over-year, driven by G&A expense reductions and operational efficiencies.
positiveExcess and Surplus (E&S) Lines segment showed strong performance with a combined ratio of 86.0% and an underwriting profit of $19.7 million, the best quarterly result since 2022.
positiveTangible common equity per share grew 34% to $8.94 since December 31, 2024.
positiveGross written premiums declined 27% year-over-year to $262.7 million, primarily driven by a 15% decrease in the E&S segment and a 70% decrease in the Specialty Admitted Insurance segment.
attentionSpecialty Admitted Insurance segment experienced a significant decline in gross written premiums (-70.3%) and net earned premiums (-65.0%), resulting in an underwriting loss of $3.6 million for the quarter.
negativeNet investment income declined 4% year-over-year to $21.0 million, impacted by lower average market yields in the bank loan portfolio and lower income from the common stock portfolio.
attentionNet realized and unrealized losses on investments were $2.2 million for the twelve months ended December 31, 2025, compared to net gains of $3.6 million in the prior year.
attentionMargin expansion indicates improving profitability and operational efficiency. Measured in basis points (bps): 100 bps = 1.0%.
| Segment | Current | Prior Yr | YoY | % Total |
|---|---|---|---|---|
Excess and Surplus Lines | N/A | — | — | — |
Specialty Admitted Insurance | N/A | — | — | — |
| Total Revenue | $0.00M | — | — | 100.0% |
Segment performance shows business unit health and growth drivers.
Special items are non-recurring events that may distort period-over-period comparisons. Analysts typically adjust for these when calculating normalized earnings.
Throughout 2025, our Company remained disciplined and focused on creating value for our shareholders, and our fourth-quarter results reflect the tangible momentum created by that work.
The strategic actions, underwriting changes, and focus on smaller insureds that we have driven over the past few years have strengthened our organization while improving our profitability and operational efficiency.
This year's results provide a strong foundation to build upon for 2026 as we continue to pursue compelling opportunities across the E&S market.
Commentary excerpts from earnings call transcripts provide management's perspective on performance, strategy, and outlook. Always review full transcripts for complete context.
Operational metrics provide insight into business drivers and customer engagement beyond traditional financial measures.